Type 1 diabetes
Conditions
Interventions
The remaining samples of the antibody detection observation group:None
Sponsors
Shaoxing People’s Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Remaining samples tested for blood glucose, insulin autoantibody (IAA), islet cell antibody (ICA), glutamate decarboxylase antibody (GAD-Ab) and other related antibodies, such as related conditions described in the intended use of the instructions (such as suspected samples of type 1 diabetes). 2.The remaining amount of samples after routine clinical tests should be sufficient to complete the tests required by clinical trials. 3.The sample should have corresponding clinical basic information, including: the subject's unique traceability number, age, gender, sample collection date, clinical diagnosis, etc.
Exclusion criteria
Exclusion criteria: 1. The sample size is insufficient to conduct the experiment. 2. Improper sample storage (such as contamination, exposure to inappropriate storage temperatures, etc.); 3. Samples with incomplete information, including patient traceability number, age, gender, sample collection date, clinical diagnosis, etc. 4. Severe hemolysis and high-concentration lipid-blood samples; 5. Other circumstances that the researcher deems ineligible for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ZnT8 test result; | — |
Countries
China
Contacts
Public ContactZhang Lihong
Shaoxing People's Hospital
Outcome results
None listed